Tau fibrils induce glial inflammation and neuropathology via TLR2 in Alzheimer’s disease–related mouse models
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Glial activation and inflammation coincide with neurofibrillary tangle (NFT) formation in neurons. However, the mechanism behind the interaction between tau fibrils and glia is poorly understood. Here, we found that tau preformed fibrils (PFFs) caused induction of inflammation in microglia by specifically activating the TLR2/MyD88, but not the TLR4/MyD88, pathway. Accordingly, the WT TLR2-interacting domain of MyD88 (wtTIDM) peptide inhibited tau PFF-induced activation of the TLR2/MyD88/NF-κB pathway, resulting in reduced inflammation. Nasal administration of wtTIDM in P301S tau-expressing PS19 mice was found to inhibit gliosis and inflammatory markers, as well as to reduce pathogenic tau in the hippocampus, resulting in improved cognitive behavior in PS19 mice. The inhibitory effect of wtTIDM on tau pathology was absent in PS19 mice lacking TLR2, reinforcing the essential involvement of TLR2 in wtTIDM-mediated effects in vivo. Studying the mechanism further, we found that the tau promoter harbored a potential NF-κB-binding site and that proinflammatory molecules increased transcription of tau in neurons via NF-κB. These results suggest that tau-induced neuroinflammation and neuropathology require TLR2 and that neuroinflammation directly upregulates tau in neurons via NF-κB, highlighting a direct connection between inflammation and tauopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Brain-derived tau proteins may activate the inflammatory response in microglia via the TLR2/MyD88/NF-κB pathway.251”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [251]
The cited source says what the claim attributes to it.
In the citing paper
“According to recent studies, pro-inflammatory cytokines like IL-1β may induce an increase in tau transcription in human primary neurons by activating the NF-κB signaling pathway in neurons.”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [251]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492 · cited 1×
“Tau proteins in humans exist in 6 different isoforms resulting from the alternative splicing of the pre-mRNA forming 3R and 4R tau species (3).”
BackgroundLee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480 · cited 2×
“Therefore, blocking TLR2/MyD88/ NF-κB–mediated inflammation with the synthetic peptide wtTIDM holds potential therapeutic value against AD, PSP, FTD, CBD, and other tauopathies.”
BackgroundTau in physiology and pathology
Wang, Y., & Mandelkow, E. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.1 · Cited by 2,251 · cited 1×
“Mutated tau has a higher tendency to self-aggregate and form paired helical filaments, which is dependent on its R2 and R3 regions at the C-terminus (29) and might also be dependent on heavy phosphorylation of certain residues (30, 31).”
BackgroundSynapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208 · cited 6×
“PS19 mice expressing P301S mutated human tau protein specifically in neurons are known to develop tau pathology with characteristic NFT formation by 6 months of age, whereas neuronal degeneration in the hippocampus is observed by 9 months of age (15).”
BackgroundMethodInfluentialDepletion of microglia and inhibition of exosome synthesis halt tau propagation
Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., Wolozin, B., Butovsky, O., Kügler, S., & Ikezu, T. (2015) · Nature Neuroscience · doi:10.1038/nn.4132 · Cited by 1,591 · cited 1×
“(9), depletion of microglia halts tau propagation.”
PSD-95 Involvement in Maturation of Excitatory Synapses
El-Husseini, A. E.-D., Schnell, E., Chetkovich, D. M., Nicoll, R. A., & Bredt, D. S. (2000) · Science · doi:10.1126/science.290.5495.1364 · Cited by 1,303 · cited 1×
“PSD95 is greatly implicated in scaffolding of multiple receptor proteins activated by the excitatory neurotransmitter glutamate and in promoting glutamate receptor–mediated Ca influx required for memory formation (48, 49).”
BackgroundBlock of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
Yun, S. P., Kam, T.-I., Panicker, N., Kim, S., Oh, Y., Park, J.-S., Kwon, S.-H., Park, Y. J., Karuppagounder, S. S., Park, H., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0051-5 · Cited by 1,123 · cited 1×
“It is also noteworthy that astroglial upregulation of TLR2 and MyD88 under pathological conditions can lead to astroglial inflammation, whereas microglial activation can further boost generation of inflammatory molecules by astrocytes (46).”
Backgroundvon Bergen, M., Friedhoff, P., Biernat, J., Heberle, J., Mandelkow, E.-M., & Mandelkow, E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5129 · Cited by 1,021 · cited 1×
“Mutated tau has a higher tendency to self-aggregate and form paired helical filaments, which is dependent on its R2 and R3 regions at the C-terminus (29) and might also be dependent on heavy phosphorylation of certain residues (30, 31).”
BackgroundKim, C., Ho, D.-H., Suk, J.-E., You, S., Michael, S., Kang, J., Joong Lee, S., Masliah, E., Hwang, D., Lee, H.-J., et al. (2013) · Nature Communications · doi:10.1038/ncomms2534 · Cited by 856
Tau and neurodegenerative disease: the story so far
Iqbal, K., Liu, F., & Gong, C.-X. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.225 · Cited by 806 · cited 1×
“Mutated tau has a higher tendency to self-aggregate and form paired helical filaments, which is dependent on its R2 and R3 regions at the C-terminus (29) and might also be dependent on heavy phosphorylation of certain residues (30, 31).”
Background
Cited by
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
“251 Research by Ising et al. suggests that tau proteins can activate the NLRP3 in fl ammasome, which then promotes excessive tau phosphorylation and aggregation by affecting speci fi c tau kinases and phosphatases.”
BackgroundCyclin-dependent protein kinases and cell cycle regulation in biology and disease
Pellarin, I., Dall’Acqua, A., Favero, A., Segatto, I., Rossi, V., Crestan, N., Karimbayli, J., Belletti, B., & Baldassarre, G. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02080-z · Cited by 304
The impact of physical exercise on neuroinflammation mechanism in Alzheimer’s disease
Hu, J., Huang, B., & Chen, K. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1444716 · Cited by 59
The multiple roles of chronic stress and glucocorticoids in Alzheimer's disease pathogenesis
Burke, M. R., Sotiropoulos, I., & Waites, C. L. (2024) · Trends in Neurosciences · doi:10.1016/j.tins.2024.08.015 · Cited by 46
Overlaps and divergences between tauopathies and synucleinopathies: a duet of neurodegeneration
Li, W., & Li, J. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00407-y · Cited by 38
“For example, in primary microglial culture, preformed tau fibrils activate microglia in an NF-κB-dependent manner [116].”
BackgroundLi, P., Sun, S., Zhu, X., Liu, X., Yin, R. M., Chen, Y., Chang, J., Ye, L., Gao, J., Zhao, X., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03181-9 · Cited by 42
Microglia-driven inflammation induces progressive tauopathies and synucleinopathies
Lee, S. H., Bae, E.-J., Park, S. J., & Lee, S. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01450-z · Cited by 39
Jiang, Z., Wang, J., Qin, Y., Liu, S., Luo, B., Bai, F., Wei, H., Zhang, S., Wei, J., Ding, G., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01392-0 · Cited by 38
“For example, tau fibrils induced microglial inflammation via TLR2 in AD mice, and FTLD-tau was associated with astrocyte reactivity in FTLD-tau patients [94–96].”
BackgroundFrom Immunity to Neurogenesis: Toll-like Receptors as Versatile Regulators in the Nervous System
Abarca-Merlin, D. M., Martínez-Durán, J. A., Medina-Pérez, J. D., Rodríguez-Santos, G., & Álvarez‐Arellano, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115711 · Cited by 30
“Tau fibrils in AD mouse models induced the activation of TLR2/MyD88/NF-κ B in microglia and stimulated neuroinflammation [148].”
BackgroundMicrobial amyloids in neurodegenerative amyloid diseases
Sampson, T. R. (2023) · FEBS Journal · doi:10.1111/febs.17023 · Cited by 28
Zhai, Y., Lu, K., Yuan, Y., Zhang, Z., Xue, L., Zhao, F., Xu, X., & Wang, H. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251329439 · Cited by 28
“31,32 Accumulating evidence indicates that A β can activate the NF-κ B pathway via TLR4 signaling, potentially exacerbating neuronal damage in the hippocampus.”
Li, B., Wang, L., Xiao, Y. C., Wang, Y., Wang, Y., Peng, Y., Zhang, A., Tang, Z., & Qi, X. (2025) · Phytotherapy Research · doi:10.1002/ptr.8461 · Cited by 26
Wang, Z., Jia, S., Kang, X., Chen, S., Zhang, L., Tian, Z., Liang, X., & Meng, C. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113536 · Cited by 22
TLR2 immunotherapy suppresses neuroinflammation, tau spread, and memory loss in rTg4510 mice
Kim, Y., Ryu, S.-H., Hyun, J., Cho, Y.-J., & Jung, Y. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.08.002 · Cited by 19
“A recent study reported that TLR2 interacts with tau fibrils to induce neuroinflammation in microglia (Dutta et al., 2023).”
BackgroundPathogenesis and therapeutic applications of microglia receptors in Alzheimer’s disease
Fu, J., Wang, R., He, J., Liu, X., Wang, X., Yao, J., Liu, Y., Ran, C., Ye, Q., & He, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1508023 · Cited by 25
G-protein coupled receptors in neuroinflammation, neuropharmacology, and therapeutics
Singh, A. P., Shadangi, S., & Rana, S. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117301 · Cited by 18
Wei, J., Liu, C., Qin, D., Ren, F., Duan, J., Chen, T., & Wu, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102544 · Cited by 15
Glaucoma as a Tauopathy—Is It the Missing Piece in the Glaucoma Puzzle?
Passaro, M. L., Matarazzo, F., Abbadessa, G., Pezone, A., Porcellini, A., Tranfa, F., Rinaldi, M., & Costagliola, C. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12216900 · Cited by 16
Li, B., Wang, L., Yan, X., Tang, Z., Wang, Y., Sun, T., & Qi, X. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03506-3 · Cited by 19
“Notably, NF-κB directly binds to consensus sequences within the tau promoter to enhance tau transcription [83], establishing a mechanistic link between NF-κB activation and tauopathy.”
Jiang, M., Ge, Z., Yin, S., Liu, Y., Gao, H., Lu, L., Wang, H., Chen, L., Ni, J., Pan, Y., et al. (2024) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.14109 · Cited by 15
Carman, B. L., Qin, S., Predescu, D. N., Jana, M., Cortese, R., Aldred, M. A., Gozal, D., Mokhlesi, B., & Predescu, S. A. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.04.005 · Cited by 13
Self-citationOligodendrocyte Dysfunction in Tauopathy: A Less Explored Area in Tau-Mediated Neurodegeneration
Majumder, M., & Dutta, D. (2024) · Cells · doi:10.3390/cells13131112 · Cited by 15
“Furthermore, reactive gliosis contributes to enhancing the detrimental effect of tau propagation associated with dampening of synaptic plasticity and neuronal health, as shown in several studies [139–143].”
ResultSelf-citationSpecial Issue “The Role of Toll-Like Receptors (TLRs) in Infection and Inflammation 2.0”
Kircheis, R., & Planz, O. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179709 · Cited by 26
Clec7a Signaling in Microglia Promotes Synapse Loss Associated with Tauopathy
Yang, S., Wang, J., Cao, Y., Zhang, Y., Sun, Z., Wan, P., Pi, M., Xiong, Q., Shu, X., Wang, X., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072888 · Cited by 19
“For example, pre-formed tau fiber (PFF) activates microglia through the TLR2/MyD88 pathway, which leads to microglia inflammation [8].”
Guo, X., Zhang, G., Peng, Q., Liu, H., Ye, K., Xiao, T., Liu, C., Zhang, X., Li, S., Wang, H., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106158 · Cited by 14
Study on the role and mechanism of Tan IIA in Alzheimer’s disease based on CREB-BDNF-TrkB pathway
Xiang, X., Xia, S., Zeng, Y., Wang, L., Yu, J., Liang, M., & Zhou, Y. (2024) · Neuroscience Letters · doi:10.1016/j.neulet.2024.137769 · Cited by 14
Bibliometric Analysis of Neuroinflammation and Postoperative Cognitive Dysfunction
Chen, Z., Zuo, Z., Zhang, Y., Shan, G., Zhang, L., Gong, M., Ye, Y., Ma, Y., & Jin, Y. (2025) · Brain and Behavior · doi:10.1002/brb3.70271 · Cited by 14
“…encompasses a various inflammatory factors, including IL-1 β , IL-6, nitric oxide synthase 2 (NOS2), reactive oxygen species (ROS), tumor necrosis factor-alpha (TNF-α ), cyclooxygenase-2 (COX-2), and acute phase proteins such as pentraxin-3 (Dutta et al. 2023; Ma et al. 2022; Yamanaka et al. 2017).”
Alves, R. L., Gonçalves, A., Voytyuk, I., & Harrison, D. C. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115234 · Cited by 11
P-glycoprotein and Alzheimer’s Disease: Threats and Opportunities
Asante, J., & Barger, S. W. (2025) · ASN NEURO · doi:10.1080/17590914.2025.2495632 · Cited by 11
“Tau preformed fibrils can induce inflammation in microglia (Dutta et al., 2023), and the neuroinflammatory factors these cells produce can modulate P-gp (Th � eron et al., 2003; Yu et al., 2007).”
Proposing Bromo-Epi-Androsterone (BEA) for Post-Traumatic Stress Disorder (PTSD)
Dow, C. T., & Obaid, L. (2025) · Cells · doi:10.3390/cells14141120 · Cited by 12
“A key discovery regarding co-occurrence of neuroinflammation and microglial activation came from Alzheimer’s disease research; these findings illustrate that Toll-like receptor (TLR) activation is required for resultant tauopathy of Alzheimer’s [72].”
Garcia, C., Banerjee, A., Montgomery, C. B., Adcock, L., Maezawa, I., Ramsey, J. J., Grodzki, A. C., Kim, K., & Cortopassi, G. A. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1628835 · Cited by 10
“This in fl amed state may impair normal microglial and brain function, reduce clearance of amyloid plaques, and drive AD (Hansen et al., 2018; Wang WY. et al., 2015; Guo et al., 2022; Bernier et al., 2020; Ghosh et al., 2018; Dutta et al., 2023).”
α-Synuclein Degradation in Brain Pericytes Is Mediated via Akt, ERK, and p38 MAPK Signaling Pathways
Yokoya, M., Takata, F., Iwao, T., Matsumoto, J., Tanaka, Y., Aridome, H., Yasunaga, M., Mizoguchi, J., Sano, K., & Dohgu, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041615 · Cited by 14
Sterile innate immune mechanisms in neurodegenerative diseases
Ealy, A., Serapiglia, A. M., & Panicker, N. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.111039 · Cited by 8
“These include the surface receptor CD36 (46, 47), TLR2 (48), TLR4 (49, 50), TLR5 (51), RAGE (52), and CD11b (53) (Fig.”
Recent advances in Alzheimer’s disease: From molecular mechanisms to therapeutic strategies
Rudman, M. D., Ulrich, J. D., & Holtzman, D. M. (2026) · Cell · doi:10.1016/j.cell.2026.06.006 · Cited by 19
Hong, X., Chen, T., Liu, Y., Li, J., Huang, D., Ye, K., Liao, W., Wang, Y., Liu, M., & Luan, P. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102669 · Cited by 10
The dual role of microglia in neurodegenerative diseases: A review
Zhang, N., Xiong, N., He, Y., & Zhou, L. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.111887 · Cited by 9
Campomayor, N. B., Kim, H. J., & Kim, M. (2025) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2024.224 · Cited by 11
Immune signaling and function in neurodegeneration
Latour, Y. L., & McGavern, D. B. (2026) · Journal of Clinical Investigation · doi:10.1172/jci199850 · Cited by 10
Nebulization of low-dose aspirin ameliorates Huntington’s pathology in N171-82Q transgenic mice
Mondal, S., Prieto, S., Rangasamy, S. B., Dutta, D., & Pahan, K. (2024) · NeuroImmune Pharmacology and Therapeutics · doi:10.1515/nipt-2023-0026 · Cited by 8
“NO, inducible nitric oxide synthase or iNOS, superoxide ion, etc.), cytokines (e.g. IL-1 β , IL-6, IL-8, TNF-α , etc.) [27, 45–47].”
MethodSelf-citationMcKay, M. A., Gorai, S., Paidi, R. K., Mondal, S., & Pahan, K. (2024) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230179 · Cited by 8
Self-citationCerebral hypoperfusion reduces tau accumulation
Gheni, G., Shinohara, M., Masuda‐Suzukake, M., Shindo, A., Watanabe, A., Kawai, K., Bu, G., Tomimoto, H., Hasegawa, M., & Sato, N. (2024) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.52247 · Cited by 5
Yamamoto, Y., Kubota, T., Noguchi, D., Saido, T. C., & Ohshima, T. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05248-y · Cited by 6
Gallagher, E. P., Li, S., Lee, H. S., Xu, H. W., LEE, V. M. ‐., Mach, R. H., & McManus, M. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051845 · Cited by 4
“…pharmaceuticals have also been shown to ameliorate tau-associated neurotoxicity in PS19 mice, including the microtubule-stabilizing agents epothilone D [33] and dictyostatin [69], the tau aggregation inhibitor anle138b [70], and the toll-like receptor 2 antagonist wtTIDM [71], among others [72].”
Wang, Y., Wu, Y., Wang, Y., Xiong, R., Chen, L., Cao, Y., Wang, Y., Yang, Y., Qu, Z., Xu, N., et al. (2025) · Antiviral Research · doi:10.1016/j.antiviral.2025.106133 · Cited by 5
King, K. E., Haeri, M., Swerdlow, R. H., & Wozniak, A. L. (2025) · Molecular Biology of the Cell · doi:10.1091/mbc.e24-04-0182 · Cited by 5
“Aberrant tau has been reported to induce inflammation in microglia (Dutta et al. , 2023).”
MicroRNA and Alzheimer’s disease: Diagnostic biomarkers and potential therapeutic targets
Huang, Y., Chen, Y., He, Z., Lu, W., Lai, H., Wang, Y., & Wang, J. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00002 · Cited by 8
Liu, W., Wei, R., Xu, J., Liu, Z., & Li, Y. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1684297 · Cited by 6
Majumder, M., Dutta, D., Paidi, R. K., & Pahan, K. (2025) · Brain Research · doi:10.1016/j.brainres.2025.150089 · Cited by 6
Self-citationJana, M., Mondal, S., Jana, A., & Pahan, K. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156457 · Cited by 5
Self-citationTop 100 most-cited articles on tau protein: a bibliometric analysis and evidence mapping
Chen, Z., Shan, G., Wang, X., Zuo, Y., Song, X., Ma, Y., Zhao, X., & Jin, Y. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1345225 · Cited by 3
“…involving glial cells, plays a pivotal role in the development of tau pathology, providing valuable insights for future investigations and therapeutic interventions targeting tau in AD (Chen and Yu, 2023; Dutta et al., 2023; Langworth-Green et al., 2023; Lau et al., 2023; Lee et al., 2023).”
BackgroundTLR2 regulation of NF-κB and NLRP3-driven pyroptosis in Alzheimer’s disease
Zhang, L., Wang, S., Gui, Y., Li, D., Li, K., Wang, Y., & Xu, Y. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.01.026 · Cited by 4
Paidi, R. K., Gorai, S., Mondal, S., & Pahan, K. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70432 · Cited by 2
Self-citationMikołajczak, K., Chmiel, J., & Leszek, J. (2026) · Cells · doi:10.3390/cells15121111 · Cited by 3
Wang, Q.-Q., Sun, Q.-Q., Guo, Y.-S., Yin, S., & Zhou, J. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00571-3 · Cited by 2
“Likewise, fibrillar tau triggers microglial activation and upregulates expression of inflammatory cytokines, an effect potentially mediated through Toll-like receptor 2 (TLR2)/nuclear factor-κB (NF-κB) signaling [31] (Fig.”
USP18 is a key regulator of immune function in mouse midbrain microglia
Lü, L., Jifu, C., Pei, B., Gao, X., Xu, Z., Yin, X., Xia, J., & Wang, J. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123692 · Cited by 4
Lead-induced hypertension and cognitive dysfunction: brain amyloid pathology
Zhang, Y., Yao, X., Song, Y., Wang, Y., Chen, M., Ji, X., Lin, Y., & Gu, S. (2025) · European journal of medical research · doi:10.1186/s40001-025-02965-x · Cited by 2
“…by increased expression of the microglial activation marker CD-11b and the pro-inflammatory cytokines IL-1β and IL-6, alongside a reduction in the neuroprotective GDNF. Neuroinflammation is a well-established driver of AD progression, contributing to neuronal injury and amy-loidogenesis [7, 32–34].”
Poddar, J., Rangasamy, S. B., & Pahan, K. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105742 · Cited by 4
Self-citationHalloy, N. R., Formanowicz, M., Pham, N. N. L., Hoyt, K. R., & Obrietan, K. H. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115458 · Cited by 3
Targeting innovative therapeutic approaches to the hallmarks of aging to combat Alzheimer’s disease
Izrael, M., & Frenkel, O. M. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00966 · Cited by 1
“Supporting this, Dutta et al. (2023) revealed that tau fibrils activate microglia through the TLR2/MyD88/nuclear factor κB pathway, and inhibiting this axis with a peptide reduced gliosis, tau pathology, and cognitive decline in PS19 mice, a tauopathy mouse model.”
Zhang, C., Long, W., Ni, J., Chen, Z., Wu, X., Li, M., Du, F., Zhao, Y., Shen, J., Cho, C. H., et al. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06002-8 · Cited by 1
“Multiple studies have confirmed that inhibiting NF-κB signaling and modulating NF-κB binding sites can effectively reduce Aβ protein deposition and intracellular neurofibrillary tangles, thereby improving cognitive impairment in AD [63–65].”
Gatto, R. G., Youssef, H., Fu, M.-H., Reichard, R., Lowe, V., Whitwell, J., Josephs, K., & Uruk, G. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00292-3 · Cited by 1
“The hypothesis that tau fibrils induce glial inflammation and neuropathology is supported by numerous preclinical models and clinical findings [14–16].”
Tian, C., Sun, J., Wang, J., Wang, Y., Wan, P., Sun, G., Mu, Y., Geng, M., Xu, B., & Zhang, Y. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102718 · Cited by 1
“Furthermore, tau protein has been shown to drive microglial activation and subsequent inflammation via TLR2 signaling; notably, blocking the TLR2-MyD88 interaction effectively counteracts tau-induced pathology in PS19 mice [15].”
TLR4-mediated chronic neuroinflammation has no effect on tangle pathology in a tauopathy mouse model
Basheer, N., Muhammadi, M. K., Freites, C. L., Avila, M., Momand, M. U. D., Hryntsova, N. B., Smolek, T., Katina, S., & Žilka, N. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1468602 · Cited by 2
Is it possible to maintain a plaque-free healthy brain by treadmill?
Pahan, S., & Pahan, K. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00936
“Introduction: AD is one of the most progressive neurodegenerative diseases that affect the learning, thinking, behavior, and memory functions of mostly the geriatric population (Rangasamy et al., 2018; Dutta et al., 2023).”
Self-citationEslamizade, M. J., Soleimani, Z., Davoudi, S., Saffarzadeh, F., Parvin, Z., Mehdizadeh, M., Rahdar, M., Hosseinmardi, N., & Janahmadi, M. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5140998
Tangavelou, K., Jiang, S., Dadras, S., Hulse, J. P., Sánchez, K. E., Bondu, V., Villaseñor, Z., Mandell, M. A., Peabody, J., Chackerian, B., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.10.642500 · Cited by 1
Protein kinase CK2α’ as a dual modulator of immune signaling and synaptic dysfunction in TauopathyPreprint
White, A., Gavrilyuk, P., Gu, P., Moya, R. F., Thurston, R., Fickak, A., Rozema, N. B., Keshavaram, P., Vermilyea, S., Schlichte, R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.24.661391
Yao, H., Wang, N., Huan, Z., Han, J., Zhao, M., & Ge, X. (2025) · Molecular Biology · doi:10.1134/s0026893325600539 · Cited by 1
“Among them, the TLR4-mediated MyD88/NF-κ B signaling pathway has been widely studied and is believed to play a central role in inflammatory responses [30, 31].”
Tian, X., Le, N. N., Zhao, Y., Alawamleh, D., Schwartz, A. M., Meyer, L. F., Helm, E., & Wu, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157524
“Loss of synapses in the hippocampal region in the Tau PS19 mice were previously reported [33,34], we then examined the levels of the presynaptic marker Synaptophysin and the postsynaptic marker PSD95 in the hippocampal lysate from 6-month-old mouse brains.”
White, A., Gavrilyuk, P., Gu, P., Moya, R. F., Thurston, R. H., Fickak, A., Rozema, N. B., Keshavaram, P., Vermilyea, S., Schlichte, R., et al. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00563-3
“On the other hand, pathological tau has also been shown to induce inflammation and NF-kB activation by interacting directly with inflammatory receptors such as toll-like receptors 2 [10, 11], creating a vicious cycle of worsening inflammation and tau pathology [9–12].”
Vidal, B., Badina, A. M., Dorogan, V., Schirmbeck, G. H., Sanches, E. F., Ceyzériat, K., Knoop, M. S., Abjean, L., Tsartsalis, S., Sizonenko, S. V., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.11.687784
Neuronal PARIS-STAT3 axis drives tau pathology and glial activation in Alzheimer’s diseasePreprint
Song, J.-Y., Akkentli, F., Jo, H., Park, J., Ha, S., Ochoa, J., Troncoso, J. C., Kang, S.-U., Dawson, V. L., & Dawson, T. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.06.692741
Shaikh, A., Ahmad, F., Murthy, J., Teoh, S. L., & Yahaya, M. F. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27021059
“This MCP-1 and NF-κ B feedback contributes to redox imbalance and mitochondrial dysfunction, thereby exacerbating neuronal injury and amplifying the amyloid–tau–glial cascade [32].”
Extracellular Vesicles in Tauopathies: Mechanisms and Applications
Nannuri, V., Ababneh, E., Rayes, S. E., Smith, J., Sugaya, K., & Zhao, J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27041998 · Cited by 1
“Neuroinflammation has been increasingly recognized as a key factor in tauopathy, with early-stage inflammation potentially alleviating tau pathology, but later-stage chronic inflammation worsening it [27,28].”
Sanagi, T., Okumura, M., Lin, Y., Kanemura, S., Moon, E., Heo, Y., Takahara, K., Lee, Y.-H., & Tsunematsu, T. (2026) · Biophysical Chemistry · doi:10.1016/j.bpc.2026.107599
Dissecting Alzheimer’s disease heterogeneity by cross-trait polygenic predictionPreprint
Li, W. F., Mohammed, N., Bennett, D. A. A., Kellis, M., & Tanigawa, Y. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.15.725551
Lucy, T. T., Mamun-Or-Rashid, A. N. M., Lee, D. C., Lefterov, I. M., Koldamova, R. P., & Fitz, N. F. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27115050
“…leukocyte activation, and positive regulation of phagocytosis is also consistent with tau fibril-induced microglial activation via TLR2/MyD88/NF-κ B signaling [33] and supports the concept that tau aggregates are recognized as damage-associated molecular patterns (DAMPs) by innate immune receptors.”
Neuroinflammation and Tauopathies
Zeenny, M.-N., Salame, I., Maatouk, L., & Akoury, E. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12253-4
“This phenotypic change is accompanied by metabolic changes, allowing the cells to meet a high energetic demand required for phagocytosis and inflamma - tory regulation [96 , 104 ].”
Popa, E., Popa, A. E., Boancă, M., Poroch, V., Hatneanu, A. M., Slănină, A. M., Ungureanu, M. I., Dramba, T., Petroaie, A. D., Bacușcă, A. I., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146200
“…in CD. Persistent exposure to circulating pro-inflammatory cytokines and damage-associated molecular patterns generated during immune activation may stimulate microglia, promoting the release of TNF-α , IL-6, reactive oxygen species (ROS), nitric oxide (NO), and complement factors [84,85].”
Krauklis, S. A., Keceli, S. K., Campbell, E. M., & Abbineni, P. S. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70532 · Cited by 1
Chakrabarti, S., Jana, M., Gorai, S., & Pahan, K. (2026) · NeuroImmune Pharmacology and Therapeutics · doi:10.1515/nipt-2026-0021
“TIDM peptides contain the Antennapedia homeodomain (lower case) and MyD88 (upper case) segments [8, 9, 13].”
InfluentialSelf-citationBhattacharya, H., Chakraborty, P., & Dewanjee, S. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.08.022
When Pathologies Collide: The Intersection of Tau and Alpha-Synuclein in Neurodegenerative Diseases
Hunt, J. N., & Kortagere, S. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06163-6
“Blocking this pathway with a TLR2-interacting domain peptide suppresses gliosis, inflammatory markers, and pathogenic tau accumulation in PS19 mice, improving cognitive function [132].”
InfluentialZhang, Y., Zhang, A., Seo, S., Fredrickson, C., Jung, M., Shan, X., Phu, L., Cramer, A. L., Sánchez-Priego, C., Kulkarni, V. V., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.07.749934 · Cited by 1
Li, W., Liu, Y., Zhang, H., Zhang, H., Shao, W., Hu, T., Liao, Y., Zhang, W., & Kang, X. (2026) · Biology Direct · doi:10.1186/s13062-026-00974-2 · Cited by 1
Patel, D. R., Rangasamy, S. B., Gorai, S., Paidi, R. K., & Pahan, K. (2026) · Neurochemistry International · doi:10.1016/j.neuint.2026.106270
Self-citationThe characteristics of perivascular proinflammation in 4‐repeat tauopathies
Fu, M., Uruk, G., Gatto, R. G., Reichard, R. R., Whitwell, J. L., & Josephs, K. A. (2026) · Brain Pathology · doi:10.1111/bpa.70162
“The reciprocal augmentation between tau and neuroinflammation has been proved both in vitro and in vivo [46, 47].”
Metadata
- Authors
- Dutta, D., Jana, M., Paidi, R. K., Majumder, M., Raha, S., Dasarathy, S., & Pahan, K.
- Affiliations
- Rush University Medical Center (US)
- Corresponding author
- Pahan, Kalipada
- Venue
- Journal of Clinical Investigation
- Published
- 2023-09-15
- Volume
- 133
- Issue
- 18
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC10503811
- OpenAlex
- W4385667068
- Cited by
- 87
- References
- 68
- Citations by year
- 2026: 26 · 2025: 37 · 2024: 21 · 2023: 3
- FWCI
- 15.45
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- U.S. Department of Veterans Affairs (AG069229, 1IK6 BX004982, IK6 BX004982, AG050431)
- University of Pennsylvania
- National Institutes of Health (1IK6 BX004982, AG069229, AG050431)
- National Institute on Aging (R21AG069229, R01AG050431)
- National Center for Complementary and Integrative Health (R01AT010980)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- tau fibrils, neuroinflammation, TLR2, MyD88, NF-κB signaling, microglial activation, glial activation, tauopathy, Alzheimer's disease, NF-kappaB binding site, gliosis, P301S tau, PS19 mice, cognitive behavior, hippocampus
- MeSH terms
- Neuroinflammatory Diseases, Alzheimer Disease, Animals, Disease Models, Animal, Inflammation, Mice, Transgenic, NF-kappa B, tau Proteins, Microglia, Adaptor Proteins, Signal Transducing, Toll-Like Receptor 2, Mice, Myeloid Differentiation Factor 88
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.